USD 5.79 billion
Biopsy Devices Market Size, Share, Growth Analysis, By Product (Liquid Biopsy Instruments, Needle-Based Biopsy Instruments), By Guidance Technique (Non-Image-Guided Biopsy, Image-Guided Biopsy techniques), By Application, By End Use, By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2955 |
Region:
Global |
Published Date: November, 2024
Pages:
193
|Tables:
93
|Figures:
71
Biopsy Devices Market Insights
Global Biopsy Devices Market size was valued at USD 5.79 billion in 2022 and is poised to grow from USD 6.60 billion in 2023 to USD 18.83 billion by 2031, growing at a CAGR of 14.00% in the forecast period (2024-2031).
A biopsy is a surgical technique used to remove tissue from an organ in order to assess the extent or existence of an illness, usually one that is malignant or inflammatory. Radiologists, surgeons, and interventional cardiologists typically carry it out. As a confirmatory test for coeliac disease and cancer, biopsies can be done on any organ with specialized biopsy instruments. Each biopsy tool has a different application depending on the kind of organ being examined. To execute biopsies with accuracy and minimal invasiveness, conventional biopsy devices can be supplemented with cutting-edge imaging technologies, such as CT scan, MRI, stereotactic, ultrasound, and others.
Organ biopsies, including those of the liver, kidneys, and lungs, are carried out using these integrated methods. The use of biopsy instruments is fueled by a sharp rise in the prevalence of cancer, particularly breast, prostate, and lung cancer, as well as by quick technical developments such 3D optical biopsies, MRI-targeted biopsies, and ultrasound-guided biopsies. Moreover, the rising cognizance towards chronic disease identification is stimulating growth of integrated biopsy technologies such as stereo-tactic-guided biopsy. However, the high cost of biopsy devices and lack of skilled professionals in poorer countries hinder the market's expansion.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Diagnostic Imaging Centers
Fastest Growth
Image-Guided Biopsy techniques
Growth Rate
14.00%
Global Gas Chromatography Market ($ Bn)
Country Share by North America (%)
To get more reports on the above market click here to Buy The Report
Biopsy Devices Market Segmental Analysis
Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Product
As per categorization by product, the market is classified as needle-based biopsy instruments, core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, biopsy forceps, localization wires and other products. Among these, needle-based biopsy instruments earned the largest share and continue to dominate the market. The high precision, minimal invasiveness and versatility of needle-based biopsy instruments have made them leaders in the global biopsy devices market. These instruments have benefitted from innovations like integration of advanced imaging and automation which have improved their accuracy and efficiency, hence making them suitable for different diagnostic undertakings. Their rule over other types of such devices is that this equipment provides reliable real-time tissue samples that are less painful to patients.
Core biopsy devices are set to become the fastest-growing segment in the global biopsy devices market due to their ability to obtain larger tissue samples for more accurate diagnoses. Technological progress achieved through automation and better imaging integration leads to enhanced accuracy while reducing the time taken to perform procedures. Growing incidences of cancer and the need for less invasive diagnostic techniques are key factors driving the use of core biopsy instruments; hence these devices are essential growth drivers on the market.
Analysis by Imaging Technology
Due to its real-time imaging equipment, ultrasound-guided biopsy has taken over the global biopsy devices market. The advancements in ultrasound technology like high-resolution imaging and advanced needle guidance systems have increased precision in tissue sampling, thus making this approach very efficient and commonly used for diagnostic purposes.
The global biopsy devices market is set to experience a tremendous increase in their sales owing to CT scan-guided biopsies that they can perform. Needle placements depend on incredibly detailed images produced by the machines. Better resolution and faster scans are achieved with new discoveries in this area leading to less diagnostic error and better results for patients using it. Additionally, there are more cancer cases being reported which necessitates accurate tissue collection as well as the consumer preference moving towards less invasive operations such as these ones done using CT scans.
Global Biopsy Devices Market By Product (%)
To get detailed analysis on other segments, Request For Free Sample Report
Biopsy Devices Market Regional Insights
The global biopsy devices market is primarily dominated by North America due to its advanced health care facilities, better use of innovative technologies and strong research & development endeavors. This region boasts a well-established network of health care providers and good access to state-of-the-art diagnostic apparatus thereby propelling the consumption of modernized biopsy devices. At the same time, there is a rise in the number of cancer cases and also more focus on early diagnosis and accuracy, which can help improve market development. In fact, North America is the leading region globally when it comes to the global biopsy devices market due to favorable government policies, increased spending on health care and successful companies in the area.
The rise in healthcare infrastructure, increasing cancer cases and investing more in advanced diagnostic technologies are what make Asia-Pacific the fastest-growing region in the global biopsy devices market. Therefore, the region’s large but diverse populace coupled with improved access to health services translates into a need for effective biopsy solutions. Government initiatives aimed at enhancing healthcare facilities and the growing prevalence of chronic diseases further stimulate market growth. In addition, the rapidly growing medical device industry across the region is working closely with international organizations; thus, there is an increased use of innovative biopsy technologies which has made Asia Pacific a fast-moving market leader.
Global Biopsy Devices Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Biopsy Devices Market Dynamics
Drivers
Increasing Cancer Incidence
- Global biopsy devices market is significantly driven by the increasing global cancer incidence. With cancer increasing, there is a corresponding need for precise and early diagnostic tools to help in timely healing. Therefore, this surge in demand for biopsy procedures increases the growth of innovative biopsy devices market.
Technological Advancements in Biopsy Devices
- Ongoing developments in biopsy technology like better imaging methods and automated equipment drive the growth of this market. The inventions improve diagnostic precision, lower procedural pain, and boost efficiency, thus making biopsy machines more efficient and attractive. This technological progress leads to large-scale acceptance and growth of the global market for biopsy instruments.
Restraints
Limited Accessibility in Developing Regions
- In various developing areas, the limited access to advanced biopsy technologies can hinder growth within the market. Economic limitations and inadequate healthcare systems restrict accessibility and acceptance of current biopsy instruments in these parts thus influencing their general expansion.
Risk of Procedure-Related Complications
- There are certain patients and health care providers who might avoid carrying out biopsy procedures due to associated complications, such as bleeding or infection. Procedural risks may also influence the adoption and usage of specific biopsy devices, which will in turn impede growth in the market.
Request Free Customization of this report to help us to meet your business objectives.
Biopsy Devices Market Competitive Landscape
The global biopsy devices market all over the world is very competitive with many international companies competing for market share through innovation and strategic partnerships. Leading players include Medtronic, Boston Scientific, Becton Dickinson which have advanced technologies and wide range of products. They invest in research and development to make their devices more precise and to broaden their geographical presence since the demand has been rising. Strategic acquisitions and collaborations are also important factors in sustaining competitive advantage and driving growth.
Top Player’s Company Profiles
- Becton, Dickinson and Company (US)
- Danaher Corporation (US)
- B. Braun Melsungen AG (Germany)
- Cardinal Health, Inc. (US)
- Hologic, Inc. (US)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (US)
- Fujifilm Corporation (Japan)
- Medtronic Plc (Ireland)
- Stryker Corporation (US)
- Cook Group Incorporated (US)
- Argon Medical Devices (US)
- Inrad, Inc. (US)
- Conmed Corporation (US)
- Teleflex Incorporated (US)
- Qiagen N.V. (Netherlands)
- Thermo Fisher Scientific, Inc. (US)
- Summit Medical LLC (US)
- Hill-Rom Holdings, Inc. (US)
- Gallini S.R.L (Italy)
- Transmed7, LLC (US)
- TSK Laboratory International (Japan)
- Merit Medical Systems, Inc. (US)
- Dr. Japan Co., Ltd. (Japan)
- Izi Medical Products (US)
- Planmed Oy (Finland)
- Advin Health Care (India)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bio-Rad Laboratories, Inc. (US)
- Illumina, Inc. (US)
Recent Developments
- In July 2024, In October 2023, Medtronic unveiled Hugo™ robotic-assisted biopsy platform which is the latest version of its Biopsy System. This state-of-the-art technology brings together advanced imaging and artificial intelligence (AI) in an attempt to increase precision and reduce procedure time. With the aim of boosting diagnostic results and improving the efficiency of biopsy processes, this device cements Medtronic’s position as a market leader.
- In June 2024, Hologic Inc. introduced the Affirm™ Prone Biopsy System, designed to offer superior imaging and patient comfort. This system is a breakthrough in ergonomic patterns together with better imaging abilities that help to facilitate breast biopsy accuracy. The innovation is in line with Hologic’s belief in the use of advanced biopsy methods for diagnosing breast cancer accurately.
- In August 2024, The Olympus Corporation just launched the EndoTherapy ™ biopsy forceps with better capability of movement as well as capturing tissue. These new forceps will give more control and accuracy during endoscopic biopsy operations. This move shows the commitment of Olympus to further develop the technology used in endoscopy while at the same time increasing the correctness of diagnosis for any gastrointestinal procedure.
Biopsy Devices Key Market Trends
- Rise of Image-Guided Biopsy Techniques: As their accuracy has increased and they are able to image in real time, image-guided biopsy techniques like ultrasound and CT scan guidance have gained popularity rapidly. With the application of these technologies, patient outcomes and diagnostic accuracy are improving thereby leading to growth in the market for biopsy equipment.
- Integration of AI in Biopsy Devices: As much as it may sound like a joke, the truth is that by enabling biopsy machines to utilize artificial intelligence, they have become capable of offering a diagnosis of the different diseases. Due to the AI algorithms for better image analysis, automated needle guidance and enhancement of precision, biopsies have become more effective and uniform. The future of biopsy instrument innovation and market expansion is being shaped by this trend.
Biopsy Devices Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global biopsy devices market is experiencing significant growth driven by technological advancements and the rising incidence of cancer. New tactical rectifier architectures, AI and improved biopsy techniques as well as advanced imaging integrations are boosting the precision and effectiveness which fuel market growth.
Needle-based and core biopsy devices are leading segments, reflecting the demand for precision and minimally invasive procedures. The market is, however, buoyed by constant developments from major players as well as a growing focus on early diagnosis and treatment despite challenges such as high cost and limited accessibility in developing areas. The competitive environment has been characterized by strategic innovations and partnerships, which are determining the direction of biopsy diagnostics.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 5.79 billion |
| Market size value in 2031 | USD 18.83 billion |
| Growth Rate | 14.00% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Biopsy Devices Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Biopsy Devices Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Biopsy Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Biopsy Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Biopsy Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Biopsy Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
